Loading...

mosque
partly-cloudy
°C,

Japan: Ivermectin effective against Omicron in phase III trial

January 31, 2022 / 12:34 PM
Image for the title: Japan: Ivermectin effective against Omicron in phase III trial
download-img
Sharjah24 – Reuters: Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin has been found effective for treating the Omicron variant of COVID-19 in a Phase III trial.
The trial found ivermectin has "an antiviral effect" against the variant, Kowa said without providing further details. The firm has been working with Kitasato University, a medical university in Tokyo.

Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing but promotion of the drug as a COVID-19 treatment has generated controversy.

The drug is not approved for treatment of COVID-19 in Japan and the U.S. Federal Drug Administration has repeatedly warned against its use.
January 31, 2022 / 12:34 PM

Related Topics

More on this Topic

Rotate For an optimal experience, please
rotate your device to portrait mode.